How to Advertise Botox in Canada (Without Breaking Rules)

How to Advertise Botox in Canada Without Advertising a Prescription Drug

Most of the advice online about advertising injectables was written for American clinics. It tells you to lead with the outcome, show the before-and-after, and let the reviews do the rest.

In Canada, that advice can put a clinic in front of a regulator.

The reason is a distinction that is easy to miss: Botox is a prescription drug, and advertising a prescription drug to the general public is restricted in a way that advertising a service is not. A clinic can market its consultation. It cannot market the drug the way it markets the service. That single difference changes how a treatment page, an Instagram ad and a Google ad should be written.

This article is marketing guidance for Ottawa aesthetics clinic owners. It is not legal advice, and nothing here replaces a review by your own compliance professional.

The rule that governs everything else

Health Canada's position on advertising prescription drugs to the public is narrow. Public advertising is generally limited to the name of the drug, its price, and its quantity.

It does not include a therapeutic benefit. It does not include a claim about what the drug will do for the person reading it. Health Canada's own guidance on illegal marketing of prescription drugs specifically names the kind of creative that gets clinics into difficulty: procedure videos, before-and-after imagery, and testimonials about therapeutic benefits.

Read that against a typical clinic's Instagram grid. "Before and after, three weeks, four units of Botox, she can finally stop frowning" contains the drug name, a quantity, a before-and-after image, and an implied therapeutic benefit. Four elements, one of which is permitted.

Services are treated differently from drugs. You are allowed to market the appointment: the consultation, the assessment, the practitioner, the clinic, the environment, the process. That is a substantial amount of legitimate advertising surface, and most clinics use almost none of it because they have been copying American templates.

What the colleges add on top

Provincial regulation lands on the regulated professional, which is why "who owns the clinic" determines "which rules apply". Ontario has no single med spa regulator. It has a physician college, a nursing college and others, and the requirements differ.

CPSO's Advertising policy, for physician-led clinics, sets expectations that go further than the federal rules in places. Two matter most for marketing:

• Physicians are responsible for advertising prepared on their behalf by third parties. If an agency, a freelancer or a family member writes the ad, the physician still owns the result. This is the sentence to read twice if you have ever handed your Instagram to a contractor.
• Testimonials are prohibited, and before-and-after images are subject to conditions including consent, accurate representation and de-identification unless consented, plus restrictions on unsolicited public display.

That combination rules out a large share of what a US-generated content calendar would hand you.

The four things that get Ottawa clinics into difficulty

1. Outcome language attached to the drug name. "Botox for a smoother forehead" is a benefit claim attached to a prescription drug. So is any framing that promises the reader a result.

2. Before-and-after imagery used as the lead creative in a public ad. It is the single most common pattern in aesthetics advertising and the one most constrained in Ontario for physician-led clinics.

3. Testimonials used as proof. Prohibited under CPSO, and RCDSO applies comparable restrictions on the dental side.

4. Nobody owns final approval. The most common root cause. Four people contribute, an agency schedules, and the person the college holds responsible has never read the caption.

The element almost no clinic uses: the treatment page rule

Here is the constructive part. The restriction is about the drug. It is not about the service, the consultation, the clinic, the practitioner's credentials, the assessment process, the technology used, or the questions a patient should ask before deciding.

A treatment page can be genuinely useful and rank well while staying inside the line, if it is built around the appointment rather than the product:

• What the consultation involves, step by step
• Who is qualified to assess you, and what credentialing means
• What questions to ask any clinic before booking, including this one
• What determines whether a treatment is appropriate for a given patient
• How pricing is structured, and why quotes vary
• What recovery and follow-up look like
• How the clinic protects privacy in photos and records

That is a page that answers a searcher's real questions, gives Google substance to rank, and contains no prohibited claim. It also converts better than a claim-based page, because the reader is choosing a clinic rather than a product.

How this changes your paid campaigns

Meta's own advertising policies and Canadian drug advertising rules point the same direction: creative that leads with the drug name and an outcome is the highest-risk combination on the platform.

What runs instead: consultation-led creative, practitioner credentialing, typical patient questions, clinic process, financing, and availability. That is a narrower creative brief than most clinics are used to, and it requires something a US template cannot supply — a person in Canada who knows which phrases are actually available.

This is the kind of work that sits at the centre of med spa marketing in Ottawa: treatment pages, consultation paths and paid creative designed against Canadian and Ontario requirements rather than imported ones. For clinics running paid social specifically, the same constraint shapes Meta Ads management for Ottawa clinics — ad structure, review workflow and landing-page pairing.

Three questions that need three different answers

Most clinic marketing goes wrong because one question gets asked where three are needed. They have different authorities, different consequences and different fixes.

A page can be lawful and still be refused by Google. It can satisfy Google and still put a physician in front of CPSO. Nothing on the page tells you which of the three you have cleared, so all three get checked separately, by name, before anything ships.

The two message types the federal rules leave open

Health Canada's guidance on the distinction between advertising and other activities describes two forms a consumer-directed message can take without promoting the drug's benefits:

• a reminder ad — the drug's name, its price and its quantity, with no reference to a disease state. Nothing about what the drug does.
• a help-seeking message — the concern or condition, with no reference to a specific prescription drug product.

Read those against a typical treatment page and the shape of a compliant one becomes obvious: talk about the concern and the appointment, not the molecule. A help-seeking message is also the more useful half of the pair commercially, because it is the only one that lets you write anything interesting.

Two further points from the same guidance are easy to miss. A product monograph may be posted on a corporate website, but only if that website carries no promotional material — context decides, not the document. And Health Canada runs a voluntary advertising preclearance system. Advisory opinions on consumer-directed messages about prescription drugs, and on educational material about a condition, are available from the preclearance agencies Health Canada recognises — the Pharmaceutical Advertising Advisory Board and Ad Standards. It is a free opinion from a body the regulator already works with, and it is worth having before a campaign leans on a new claim.

A workable approval workflow

Advertising fails at the approval step more often than at the writing step. A four-step workflow that holds up:

1. A claim register. One document listing every sentence about a treatment or drug that is approved for public use, and the source. Anything not on the register does not ship.
2. One named approver. A regulated professional with the authority to sign off. Without a name, approval is a vibe.
3. Assets separated by placement. Consultation content can be public. Any imagery with before-and-after or patient context goes where the policy allows, not into a public feed by default.
4. A quarterly review. Platform policies and college guidance both change. A register that was accurate in March may not be accurate in October.

What to do this week

Take your three highest-traffic treatment pages and search each one for four things: a drug name next to a benefit, a testimonial, a before-and-after image used publicly, and the absence of a named approver. Fix the last one first. Every other problem traces back to the fact that no single person was responsible for what went out.

Then rewrite the pages toward the appointment rather than the product. It is more work than swapping a headline, and it is the difference between marketing that compounds and marketing that gets pulled down.

Questions clinics ask

Can you advertise Botox in Canada?

Botox is a prescription drug, and public advertising of prescription drugs in Canada is restricted to the drug's name, price and quantity, without therapeutic benefit claims. Clinics can advertise the service side instead: the consultation, the assessment, the practitioner's credentials, the clinic and the process. Any specific campaign should be reviewed by the clinic's own compliance professional.

Can a Canadian clinic use before-and-after photos in advertising?

For physician-led clinics in Ontario, CPSO's Advertising policy sets conditions on before-and-after images, including consent, accurate representation, de-identification unless consented, and restrictions on unsolicited public display. Health Canada also names before-and-after imagery as a concern in marketing prescription drugs, alongside procedure videos and testimonials about therapeutic benefits. The safe position is to keep this imagery out of public advertising and use consultation-led creative instead.

Why can US med spa marketing advice be a problem in Ontario?

US content is written for a different advertising framework and routinely leads with outcome claims, testimonials and before-and-after creative. Ontario adds college-level requirements on top of federal rules, including restrictions on physician advertising testimonials and conditions on before-and-after images for physician-led clinics. Templates built for one framework do not transfer cleanly to the other.

Who is responsible if an agency's ad breaks the rules?

CPSO states that physicians are responsible for advertising prepared on their behalf by third parties. The clinic owns the outcome regardless of who wrote the copy or scheduled the post. That is why a named internal approver and a documented claim register matter more than choosing a careful agency.

What can a Botox treatment page say instead of promising results?

A treatment page can cover what the consultation involves, who is qualified to assess suitability, the questions to ask before booking, how pricing is structured, what follow-up looks like, and how the clinic handles privacy in photographs and records. That content answers real search questions, gives search engines substantive material, and stays on the service side of the drug-service distinction.

How often should clinic advertising be reviewed?

Quarterly is a practical baseline. Platform advertising policies, federal drug advertising guidance and college standards all change. A claim register reviewed quarterly, with one named approver and a clear rule that unregistered claims do not ship, prevents most of the problems that cause ads or pages to be taken down.

Sources

• Health Canada — Illegal marketing of prescription drugs, including the reminder-ad and help-seeking message types and the Botox examples
• Health Canada — Regulatory requirements for advertising, which names the preclearance agencies and their roles
• CPSO — Advertising policy
• Google Ads — Healthcare and medicines policy for the platform layer, which is separate from Canadian law

Checked 16 October 2026. Regulator guidance and platform policy both change; re-check the linked pages before acting on a specific campaign.